2-(2,3-Difluoro-6-methoxyphenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane, 98%, 10g

rel-4,4,5,5-Tetramethyl-2-[(1R,2S)-2-methylcyclopropyl]-1,3,2-dioxaborolane, 98%, 500mg

3-(N-Boc-N-Propylamino)phenylboronic acid, 98%, 100mg

Dimethyl tetradecanedioate, 95.0%, 25g

3-Chloro-N,4-dimethylaniline, 97%, 500mg

1-(2,6-dimethylpyridin-4-yl)piperazine, 95.0%, 250mg

5-Bromo-1,10-phenanthroline hydrate, 97.0%, 5g

Morpholino(5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridin-2-yl)methanone, 95.0%, 1g

Lámina de cobre recocida al 99,998% 0,1 x 100 x 100 mm 1 ud.

(4-{[(tert-butoxycarbonyl)(methyl)amino]methyl}phenyl)boronic acid, 95.0%, 5g

5-Methyl-3-(2',6'-dichlorophenyl)-4-isoxazolecarboxylic acid, 98.0%, 25g

Methyl 2-(Aminosulfonylmethyl)benzoate>98.0%(HPLC)(N)25g

3-[5-(chloromethyl)-1,3,4-oxadiazol-2-yl]pyridine, 95.0%, 1g